Shlomit Strulov Shachar, MD

ICRF is currently supporting nine projects in the area of breast cancer research. Meet one of the newly-funded researchers for 2021-2022 below:

Shlomit Strulov Shachar, MD, the second recipient of a Career Development Award, co-funded by ICRF and Conquer Cancer (The ASCO Foundation) at Tel Aviv Sourasky Medical Center, is focusing on Estrogen Receptor-Positive Metastatic Breast Cancer (or ER+MBC). Most ER+MBC patients respond to first-line treatment, but then drug resistance develops. Two additional drugs are given as second-line treatment, but the optimal time sequence in delivering them and whether there is any benefit in taking both drugs is unknown. The Shachar team will study the responses to these drugs, in order to determine if treatment with the second drug is warranted and to avoid an unnecessary toxicity burden to ER+MBC patients.

View Grant Recipient profile